Get Permission
Rev Diabet Stud, 2014, 11(1):51-83 DOI 10.1900/RDS.2014.11.51

Sox9: A Master Regulator of the Pancreatic Program

Philip A. Seymour

The Danish Stem Cell Center (DanStem), University of Copenhagen, Panum Institute, Blegdamsvej 3B, DK-2200, Copenhagen N, Denmark

Manuscript submitted July 26, 2013; resubmitted August 9, 2013; accepted August 10, 2013.

Keywords: Sox9, pancreas development, beta-cell, multipotent progenitor cell, Fgf, Pdx1, Notch, Hes1, transgenic mouse, molecular marker


Over the last decade, it has been discovered that the transcription factor Sox9 plays several critical roles in governing the development of the embryonic pancreas and the homeostasis of the mature organ. While analysis of pancreata from patients affected by the Sox9 haploinsufficiency syndrome campomelic dysplasia initially alluded to a functional role of Sox9 in pancreatic morphogenesis, transgenic mouse models have been instrumental in mechanistically dissecting such roles. Although initially defined as a marker and maintenance factor for pancreatic progenitors, Sox9 is now considered to fulfill additional indispensable functions during pancreogenesis and in the postnatal organ through its interactions with other transcription factors and signaling pathways such as Fgf and Notch. In addition to maintaining both multipotent and bipotent pancreatic progenitors, Sox9 is also required for initiating endocrine differentiation and maintaining pancreatic ductal identity, and it has recently been unveiled as a key player in the initiation of pancreatic cancer. These functions of Sox9 are discussed in this article, with special emphasis on the knowledge gained from various loss-of-function and lineage tracing mouse models. Also, current controversies regarding Sox9 function in healthy and injured adult pancreas and unanswered questions and avenues of future study are discussed.

Fulltext: HTML , PDF (1.4 MB)

This article has been cited by other articles:

Pancreatic beta-cell regeneration: Facultative or dedicated progenitors?

Afelik S, Rovira M

Mol Cell Endocrinol 2017. 445:85-94

Molecular mechanisms of Sox transcription factors during the development of liver, bile duct, and pancreas

Yin C

Semin Cell Dev Biol 2017. 63:68-78

The role of the signaling pathway FGF/FGFR in pancreatic cancer

Gnatenko DA, Kopantsev EP, Sverdlov ED

Biochem (Moscow) 2017. 11(2):101-110

Effects of methyl mercury exposure on pancreatic beta cell development and function

Schumacher L, Abbott LC

J Appl Toxicol 2017. 37(1):4-12

SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage

Hong X, Liu W, Song R, Shah JJ, Feng X, Tsang CK, Morgan KM, Bunting SF, Inuzuka H, Zheng XF, Shen Z, Sabaawy HE, Liu L, Pine SR

Nucleic Acids Res 2016. 44(18):8855-8869

Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases

Arvaniti E, Moulos P, Vakrakou A, Chatziantoniou C, Chadjichristos C, Kavvadas P, Charonis A, Politis PK

Sci Rep 2016. 6:26235

miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9

Li Z, Li B, Niu L, Ge L

Oncol Rep 2016. In press

Progenitor cell niches in the human pancreatic duct system and associated pancreatic duct glands: an anatomical and immunophenotyping study

Carpino G, Renzi A, Cardinale V, Franchitto A, Onori P, Overi D, Rossi M, Berloco PB, Alvaro D, Reid LM, Gaudio E

J Anat 2016. 228(3):474-486

Pancreatic Cancer Genetics

Amundadottir LT

Int J Biol Sci 2016. 12(3):314-325

Centroacinar cells: At the center of pancreas regeneration

Beer RL, Parsons MJ, Rovira M

Dev Biol 2016. 413(1):8-15

Recent advance in diabetes therapy: pancreatic beta cell regeneration approaches

Chala TS, Ali GY

Diabetes Manag (Lond) 2016. 6(6):108-118

Role of fibroblast growth factors in pancreatic cancer

Gnatenko DA, Kopantsev EP, Sverdlov ED

Biomed Khim 2016. 62(6):622-629

Endocrine Pancreas Development and Regeneration: Noncanonical Ideas From Neural Stem Cell Biology

Masjkur J, Poser SW, Nikolakopoulou P, Chrousos G, McKay RD, Bornstein SR, Jones PM, Androutsellis-Theotokis A

Diabetes 2016. 65(2):314-330

Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells

Pini J, Rouleau M, Desnuelle C, Sacconi S, Bendahhou S

Stem Cells Dev 2016. 25(2):151-159

Developmental Molecular Biology of the Pancreas

Murtaugh LC, Cleaver O, MacDonald RJ

Pancreat Cancer 2016. In press

Circulating microRNAs in Diabetes Progression: Discovery, Validation, and Research Translation

Farr RJ, Joglekar MV, Hardikar AA

EXS 2015. 106:215-44

Pax4 acts as a key player in pancreas development and plasticity

Napolitano T, Avolio F, Courtney M, Vieira A, Druelle N, Ben-Othman N, Hadzic B, Navarro S, Collombat P

Semin Cell Dev Biol 2015. 44:107-114